Comparison of intermediate-dose purified urinary follicle-stimulating hormone with and without human chorionic gonadotropin for ovulation induction in polycystic ovarian disease**Supported in part by a grant from Serono Pharmaceutical Company, Randolph, Massachusetts.
Claman, Paul, Seibel, Machelle M., McArdle, Colin, Berger, Merle J., Taymor, Melvin L.Volume:
46
Language:
english
Journal:
Fertility and Sterility
DOI:
10.1016/s0015-0282(16)49597-x
Date:
September, 1986
File:
PDF, 503 KB
english, 1986